Alloksys Life Sciences B.V.

Quick facts

Phase 3 pipeline

• bIAP bolus and 8h infusion · Inflammatory diseases
  bIAP is a caspase-1 inhibitor that blocks the activation of inflammatory caspases.
• placebo bolus and 8h infusion
  This drug is a placebo, meaning it has no active therapeutic effect.

Phase 2 pipeline

• RESCAP®

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Alloksys Life Sciences B.V. portfolio CI brief
• Alloksys Life Sciences B.V. pipeline updates RSS